This Month's Supplements

 
 

@RetinaToday

http://t.co/Q414Uwij3L > Retina in 2015: What to Expect in Government Policy > http://t.co/WXXo29B8Vh

Articles From This Issue


 

Data Release in the Public Interest

Clinical trial data informs just about everything we do as physicians. There have been several instances where the results from a controlled clinical trial in a large populati…

Medical Update

Cleveland Clinic Chose Top 10 Medical Innovations for 2015 The Cleveland Clinic announced its list of the top 10 medical innovations that are likely to have a major impa…

 
Uveitis Resource Center

advertisement

NEWS


 

FDA Grants Breakthrough Therapy Designation for Lucentis for the Treatment of Diabetic Retinopathy

The FDA has granted breakthrough therapy designation for Lucentis (ranibizumab; Genentech) for the t…

News

Retina specialists performing vitrectomy procedures billed through Medicare will receive reduce…

Video Series


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Bryan Bechtel
Editor-in-Chief
484-581-1827
bbechtel@bmctoday.com

Alan B. Guralnick
Publisher
484-581-1832
aguralnick@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.

Website Design by Sides Media